The 14-week quote that became nine months

How many of your portfolio companies' manufacturing timelines actually went the way the deal model assumed? In my experience, almost none of them.

What happened

Here's one I keep coming back to. During diligence, a vendor quoted 14 weeks on a piece of production equipment central to the ramp plan. It was in the data room, nobody disputed it, and the integration schedule was built around that number.

By the time the purchase order actually went out, three months after close, the same vendor's backlog had grown and the real lead time was closer to nine months. Then came installation. Then qualification. Then process validation.

Nobody misrepresented anything. The quote was accurate the day it was given. It just wasn't the number anyone repriced between the data room and the signature.

By the time that mattered, it was already load-bearing in the 100-day plan.

Why one number moves the whole schedule

In a regulated manufacturing environment, equipment lead time is rarely the end of the story. Each step after delivery depends on the one before it: installation, equipment qualification, then process validation before product can ship. A slip at the front of that chain doesn't add a few weeks at the end. It moves everything behind it, including the revenue ramp the model assumes.

Treat long-lead equipment as its own line of diligence

I now treat long-lead equipment as its own line of diligence, reconfirmed close to close rather than quoted once and filed. In practice, that means:

• Identify the critical items. Which pieces of equipment does the ramp plan actually depend on, and which have no practical alternative?
• Get current lead times in writing, with the date of the quote and how long it's valid, rather than relying on a number already in the data room.
• Ask about the vendor's backlog, not just their standard lead time.
• Reconfirm before signing. If the deal has taken months to close, the quote from the start of diligence may no longer describe reality.
• Build the full chain into the schedule: delivery, installation, qualification and validation, so the 100-day plan reflects when product can actually ship.

Chris Steadham is the founder of Truestead Advisors and has spent 30+ years in medical device product development, manufacturing scale-up and general management. Working through a question like this on a deal or a program? Start a conversation.